Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

New Colon Cancer Screening Guidelines Add Blood And At-Home Tests By Dennis Thompson HealthDay ReporterTHURSDAY, May 28, 2026 (HealthDay News) — Blood tests taken in a doctor’s office now can be used ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Colorectal cancer is now the leading cause of cancer-related death among adults under 50 in the United States, and diagnoses in younger adults continue to increase at an alarming rate. In fact, it has ...

When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...

See more Winnipeg Sun on Google - pleasesave as a Preferred Source ...

Ontario has lowered the eligibility age for colon cancer screening from 50 to 45, a move that cancer survivor Ashley Wiley ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit ...